Posterior Reversible Encephalopathy Syndrome and Stroke after Intravenous Immunoglobulin Treatment in Miller–Fisher Syndrome/Bickerstaff Brain Stem Encephalitis Overlap Syndrome-Reference-Cited by-同舟云学术

Posterior Reversible Encephalopathy Syndrome and Stroke after Intravenous Immunoglobulin Treatment in Miller–Fisher Syndrome/Bickerstaff Brain Stem Encephalitis Overlap Syndrome

Published:2014-10 Issue:9 Volume:23 Page:e423-e425
ISSN:1052-3057
Container-title:Journal of Stroke and Cerebrovascular Diseases
language:en
Short-container-title:Journal of Stroke and Cerebrovascular Diseases

Author:

Stetefeld Henning R.,Lehmann Helmar C.,Fink Gereon R.,Burghaus Lothar

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Neurology (clinical),Rehabilitation,Surgery

Reference14 articles.

1. A reversible posterior leukoencephalopathy syndrome;Hinchey;N Engl J Med,1996

2. Posterior reversible encephalopathy syndrome: a review;Feske;Semin Neurol,2011

3. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin;Voltz;Neurology,1996

4. Neuropathologic findings in a Guillain-Barré patient with strokes after IVIg therapy;Byrne;Neurology,2002

5. Posterior reversible encephalopathy and Guillain-Barré syndrome in a single patient: coincidence or causative relation?;Van Diest;Clin Neurol Neurosurg,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple cerebral infarctions after intravenous immunoglobulin for Guillain–Barré syndrome: two case reports and review of the literature;Frontiers in Immunology;2024-07-23

2. Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee;Muscle & Nerve;2023-07-11

3. Posterior reversible encephalopathy syndrome and autoimmunity;Autoimmunity Reviews;2023-02

4. Posterior reversible encephalopathy syndrome associated with mild COVID-19 infection in a 9-year-old child: A case report and literature review;IDCases;2023

5. Prevention of Adverse Outcomes and Treatment Side Effects in Patients with Neuromuscular Disorders;Seminars in Neurology;2022-10